Stocks
Allergan (AGN) EBITDA margin US GAAP (year values) |
|||||||||
| 2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 75.2% | 144.1% | -14.6% | 5.02% | 10.7% | 16.9% | ||
| Changes by years, y/y, % | +64pp | +69pp | -159pp | +20pp | +6pp | -1.8% | |||
Allergan. EBITDA margin, %
Allergan. EBITDA margin, changes, pp
Allergan (AGN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | LTM ? | |||
| EBITDA margin, % | ? | -23.0% | 4.61% | 25.1% | 30.8% | 4.69% | 16.9% | |
| Changes by years, y/y, % | -51pp | -32pp | -27pp | +123pp | +28pp | |||
| Changes by quarters, q/q, % | +69pp | +28pp | +21pp | +6pp | -26pp | |||
